"Transforming Information Into Intelligence"

We’ve teamed up with industry leaders across the world to discuss the current and future trends of the Wound Care market.

And guess what…

“Chronic non-healing wounds cost more than heart-failure and have a higher mortality rate than breast or colon cancer but there is no comparable investment in research.”


Executive Director of the US Wound Registry
Elizabeth Thomas The Health Exchange Market

With our host, Elizabeth Thomas!

Based out of Nashville, Tennessee, The Health Exchange Market is the commercialization launching pad for healthcare data and research that connects buyers and sellers. As a leading partner of the wound care industry, we’re here to do everything we can to promote innovation, collaboration, and a better healthcare system for everyone.

Together, we are addressing the growing pains of wound care...

THEM has the perfect cast!

Collin has worked for the State of South Carolina legislation, USC public health department, HCA, an EMR company and healthcare startups. He earned a Healthcare MBA from Belmont University, a BA Public Health from the University of South Carolina, a Certificate in Ethical Leadership, a Lean Healthcare Certificate, Certified Training in Negotiations from Harvard University, and is active on HL7s Orders and Observations Committee. He is currently the Founder and CEO The Health Exchange Market (T.H.E.M.) in Nashville, TN.

Gurdyal Kalsi The Health Exchange Market
Dr. Kalsi has served in many capacities with a therapeutic focus for over 20 years in oncology (immune therapeutics, biologics), hematology, infectious diseases, inflammatory disorders, autoimmune disorders, vaccines, gastroenterology, cell and gene therapies and rare genetic disorders.
He has a passion for all things that hurt, and is currently the Chief Medical Officer at Asklepion Pharmaceuticals.

Andy has over 20 years of experience in IT, medical device, and regenerative biotech representing a wide range of companies across multiple medical disciplines. He has a passion for bringing innovation to providers, care continuum protocols, and using evidence-based and data-driven solutions for better patient outcomes and the betterment of all stakeholders. He is the acting VP of sales for R4 Bio Therapeutics, a multi-faceted distribution company focused primarily on advanced biologics and regenerative therapies.